Tue 6/2/2020 14:16 ET
DJIA25642.23169.240.66%TELCO169.380.240.14%GOLD1731.6018.351.06%Shanghai2921.405.840.20%
S&P 5003068.4412.890.42%BANKS346.272.490.72%OIL35.341.634.61%BITCOIN9522.05594.186.24%
NASDAQ9563.5211.480.12%PHARM609.113.590.59%US/EU1.120.000.31%Futures3057.2519.260.63%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neurocrine Biosciences - NBIX   

Return Top | Return List | Reply Thread | Search | Add NBIX | Ignore NBIX
From: Sqwii (Rep: 389)Date: 2012-05-11 03:47:39
Forum: Neurocrine Biosciences - Thread #673400691Msg #1077 - Part 1/1 (Rec: 0)
NBIX another one I like here at 6.96$ for some news coming near term this month



Urocortin 2 Update
The Christchurch Cardioendocrine Research Group at University of Otago, Christchurch School of Medicine and Health Sciences, New Zealand, in collaboration with the Company, is conducting a Phase II study of urocortin 2 in acute decompensated heart failure patients. This study is now complete and top-line results are expected shortly.

The Company has completed several Phase I studies and two Phase II studies of urocortin 2 in patients with stable congestive heart failure. These Phase II studies showed urocortin 2 to be well tolerated with positive hemodynamic effects as evidenced by increases in cardiac output and efficiency.

Started my own blog www.SqwiiTrader.com

Message: Endorse | Reply | Privately | Bookmark | Report Abuse User Sqwii: Reward | Watch | Ignore


TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.